tm
Seeing Is Believing
tm
Seeing Is Believing
SYRE is currently covered by 8 analysts with an average price target of $103. This is a potential upside of $34.37 (13.44%) from yesterday's end of day stock price of $90.8.
Spyre Therapeutics's activity chart (see below) currently has 17 price targets and 43 ratings on display. The stock rating distribution of SYRE is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 83.09% with an average time for these price targets to be met of 236.38 days.
Highest price target for SYRE is $135, Lowest price target is $65, average price target is $103.
Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH. First documented stock forecast 10-Dec-2023.
Currently out of the existing stock ratings of SYRE, 28 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Sep-2024
$123
$32.4 (35.76%)
$123
Buy Since 10-May-2024
$121
$30.4 (33.55%)
$121
7 days ago
(08-Sep-2026)
8/11 (72.73%)
$30.21 (33.27%)
203
Buy Since 26-Sep-2025
$127
$36.4 (40.18%)
$135
20 days ago
(26-Aug-2026)
2/5 (40%)
$33.39 (35.67%)
106
Buy Since 13-May-2024
$115
$24.4 (26.93%)
$90
1 months 10 days ago
(05-Aug-2026)
4/5 (80%)
$10.65 (10.21%)
190
Buy Since 25-Oct-2024
$130
$39.4 (43.49%)
$65
1 months 10 days ago
(05-Aug-2026)
2/3 (66.67%)
$25.65 (24.58%)
364
What is SYRE (Spyre Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on SYRE (Spyre Therapeutics)?
Which analyst has the most public recommendations on SYRE (Spyre Therapeutics)?
Which analyst is the currently most bullish on SYRE (Spyre Therapeutics)?
Which analyst is the currently most reserved on SYRE (Spyre Therapeutics)?
